ECE2013 Poster Presentations Adrenal cortex (64 abstracts)
Genetic analysis does not confirm NCCAH in almost half of the women who had received this diagnosis: preliminary results of an audit
Valeria Alcántara 1 , Diana Tundidor 1 , Susan Webb 1, , Gemma Carreras 1 , Juan Jose Espinos 1 , Ana Isabel Chico 1 , Silvia Martínez 1 , Francisco Blanco 1 & Rosa Corcoy 1
1Hospital de la Santa Creu I Sant Pau, Barcelona, Spain; 2CIBERER 747, Barcelona, Spain.
Introduction: Non-classical congenital adrenal hyperplasia (NCCAH) due to 21-hydroxylase deficiency is one of the most frequent autosomal recessive diseases. Genetic analysis performed for genetic counselling revealed a miscorrelation with the clinical diagnosis in several patients at our centre.
Aim: Confirm the genetic diagnosis of NCCAH in women attended for this condition.
Materials and methods: Consecutive patients attended at our centre are to be included. So far 26 patients have undergone medical record study collecting clinical, hormonal, and therapeutic information at diagnosis and follow-up into a standardized database. Analysis of the 21-hydroxylase gene has been performed through polymerase chain reaction, sequencing, and family genetic testing when possible.
Statistics: Descriptive analysis; data are expressed as percentages and medians(P25, P75).
Results: 84.6% of the patients were index cases. Age at first symptom was 16 years (9.23) and the number of symptoms was 2 (1–3). The most common manifestations were hirsutism (66.7%), oligomenorrhea (50.0%), infertility (15.4%), acne (11.5%), and alopecia (11.5%). At diagnosis, basal 17-hydroxyprogesterone(17OHP) was available in 73% of patients (21.6 nmol/l (6.97, 41)) and ACTH stimulation for 17OHP in 23% (141.9 (52, 175.2)). Genetic analysis revealed that 11.5% of the patients had no mutations, 30.8% were heterozygous for a single mild mutation, 30.7% homozygous for a mild mutation, and 26.9% compound heterozygotes for one mild and one severe mutation. The most common mutation was mild Val281Leu. Globally 42.3% of the patients’ genetic results did not confirm their clinical diagnosis.
Conclusion: In a substantial subset of patients in follow-up for NCCAH, hormonal work-up at diagnosis was inadequate. In almost half of the patients the genotype did not confirm the diagnosis. The diagnosis was confirmed in 81.3% of those with a sufficient hormonal diagnosis and in 20% of those with an insufficient one. These results compel us to reconsider the diagnostic and therapeutic requirements of these patients.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more